Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-22-000008

Options or other derivatives

  • Chief Executive Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BUNKA CHRISTOPHER Chief Executive Officer 2022-08-29 Grant or award · Stock Options +30,000 101,001 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…